Pricing
Login
Home
Charts
Search
Watchlist
Products

Corona Remedies Ltd

CORONA
₹2,263.20+1.18%20 Nov 2026
Reports
Pharma Formulations

Corona Remedies Ltd

CORONA
₹2,263.20
+1.18%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹13,842Cr
Close
Close Price
₹2,263.20
Industry
Industry
Pharma Formulations
PE
Price To Earnings
66.86
PS
Price To Sales
8.88
Revenue
Revenue
₹1,559Cr
Rev Gr TTM
Revenue Growth TTM
20.02%
PAT Gr TTM
PAT Growth TTM
18.28%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
314298294347361342353422441
Growth YoY
Revenue Growth YoY%
15.115.020.221.922.2
Expenses
ExpensesCr
247228239277283259291329345
Operating Profit
Operating ProfitCr
676954707883629396
OPM
OPM%
21.323.318.520.121.724.317.622.121.8
Other Income
Other IncomeCr
21222-17433
Interest Expense
Interest ExpenseCr
322222133
Depreciation
DepreciationCr
91010999101315
PBT
PBTCr
575844617055558081
Tax
TaxCr
14131214171492020
PAT
PATCr
434532465241456060
Growth YoY
PAT Growth YoY%
21.8-8.243.730.115.3
NPM
NPM%
13.715.110.713.314.512.112.814.213.7
EPS
EPS₹
7.07.35.27.58.66.87.49.89.9
QuarterSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
314298294347361342353422441
Growth YoY
Revenue Growth YoY%
15.115.020.221.922.2
Expenses
ExpensesCr
247228239277283259291329345
Operating Profit
Operating ProfitCr
676954707883629396
OPM
OPM%
21.323.318.520.121.724.317.622.121.8
Other Income
Other IncomeCr
21222-17433
Interest Expense
Interest ExpenseCr
322222133
Depreciation
DepreciationCr
91010999101315
PBT
PBTCr
575844617055558081
Tax
TaxCr
14131214171492020
PAT
PATCr
434532465241456060
Growth YoY
PAT Growth YoY%
21.8-8.243.730.115.3
NPM
NPM%
13.715.110.713.314.512.112.814.213.7
EPS
EPS₹
7.07.35.27.58.66.87.49.89.9

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
8841,0141,1961,4031,559
Growth
Revenue Growth%
14.817.917.320.0
Expenses
ExpensesCr
7568609561,1101,225
Operating Profit
Operating ProfitCr
128155240293334
OPM
OPM%
14.515.320.120.921.4
Other Income
Other IncomeCr
766-8-7
Interest Expense
Interest ExpenseCr
4141178
Depreciation
DepreciationCr
2028373848
PBT
PBTCr
111118199240271
Tax
TaxCr
2628495564
PAT
PATCr
8591149185207
Growth
PAT Growth%
6.665.123.918.3
NPM
NPM%
9.68.912.513.213.3
EPS
EPS₹
14.614.824.430.333.9
Financial YearMar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
8841,0141,1961,4031,559
Growth
Revenue Growth%
14.817.917.320.0
Expenses
ExpensesCr
7568609561,1101,225
Operating Profit
Operating ProfitCr
128155240293334
OPM
OPM%
14.515.320.120.921.4
Other Income
Other IncomeCr
766-8-7
Interest Expense
Interest ExpenseCr
4141178
Depreciation
DepreciationCr
2028373848
PBT
PBTCr
111118199240271
Tax
TaxCr
2628495564
PAT
PATCr
8591149185207
Growth
PAT Growth%
6.665.123.918.3
NPM
NPM%
9.68.912.513.213.3
EPS
EPS₹
14.614.824.430.333.9
Sales CAGR
1 Year17%
3 Years17%
5 Years-
TTM20%
EBITDA CAGR
1 Year22%
3 Years32%
5 Years-
TTM23%
PAT CAGR
1 Year24%
3 Years30%
5 Years-
TTM18%
Avg. ROCE
1 Year27%
3 Years26%
5 Years-
TTM31%
CFO / EBITDA
1 Year78%
3 Years84%
5 Years-
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
6161616161
Reserves
ReservesCr
347419545686744
Current Liabilities
Current LiabilitiesCr
137224240361333
Non Current Liabilities
Non Current LiabilitiesCr
491268497109
Total Liabilities
Total LiabilitiesCr
5958319301,2051,247
Current Assets
Current AssetsCr
291290339348474
Non Current Assets
Non Current AssetsCr
304541591857773
Total Assets
Total AssetsCr
5958319301,2051,247
Financial YearMar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
6161616161
Reserves
ReservesCr
347419545686744
Current Liabilities
Current LiabilitiesCr
137224240361333
Non Current Liabilities
Non Current LiabilitiesCr
491268497109
Total Liabilities
Total LiabilitiesCr
5958319301,2051,247
Current Assets
Current AssetsCr
291290339348474
Non Current Assets
Non Current AssetsCr
304541591857773
Total Assets
Total AssetsCr
5958319301,2051,247

Cash Flow

Consolidated
Standalone
Financial YearMar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
103157190229
Investing Cash Flow
Investing Cash FlowCr
-50-267-84-256
Financing Cash Flow
Financing Cash FlowCr
-4599-10725
Net Cash Flow
Net Cash FlowCr
8-110-1
Free Cash Flow
Free Cash FlowCr
9-1299956
CFO To PAT
CFO To PAT%
120.9173.2127.5124.0
CFO To EBITDA
CFO To EBITDA%
80.3101.379.478.2
Financial YearMar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
103157190229
Investing Cash Flow
Investing Cash FlowCr
-50-267-84-256
Financing Cash Flow
Financing Cash FlowCr
-4599-10725
Net Cash Flow
Net Cash FlowCr
8-110-1
Free Cash Flow
Free Cash FlowCr
9-1299956
CFO To PAT
CFO To PAT%
120.9173.2127.5124.0
CFO To EBITDA
CFO To EBITDA%
80.3101.379.478.2

Ratios

Consolidated
Standalone
Financial YearMar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
9,51713,842
Price To Earnings
Price To Earnings
51.466.9
Price To Sales
Price To Sales
6.88.9
Price To Book
Price To Book
12.717.2
EV To EBITDA
EV To EBITDA
32.941.5
Profitability Ratios
Profitability Ratios
GPM
GPM%
75.276.579.280.280.2
OPM
OPM%
14.515.320.120.921.4
NPM
NPM%
9.68.912.513.213.3
ROCE
ROCE%
26.420.830.227.131.1
ROE
ROE%
20.818.824.624.825.7
ROA
ROA%
14.310.916.115.416.6
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
9,51713,842
Price To Earnings
Price To Earnings
51.466.9
Price To Sales
Price To Sales
6.88.9
Price To Book
Price To Book
12.717.2
EV To EBITDA
EV To EBITDA
32.941.5
Profitability Ratios
Profitability Ratios
GPM
GPM%
75.276.579.280.280.2
OPM
OPM%
14.515.320.120.921.4
NPM
NPM%
9.68.912.513.213.3
ROCE
ROCE%
26.420.830.227.131.1
ROE
ROE%
20.818.824.624.825.7
ROA
ROA%
14.310.916.115.416.6
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr15,97415,42414,89413,84213,19610,9588,917
Close PriceClose₹814.302,029.10935.052,263.20291.15696.20967.30
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE17.7422.3856.2966.8623.5629.3014.46
Price To SalesPS5.176.471.658.883.892.271.71
RevenueRevenueCr3,0892,3839,0121,5593,3924,8265,213
Revenue Growth TTMRev Gr TTM%-29.6%16.8%18.3%20.0%24.2%17.5%11.3%
PAT Growth TTMPAT Gr TTM%-56.4%17.4%-44.7%18.3%60.2%12.8%54.3%
Market CapitalizationMkt CapCr15,97415,42414,89413,84213,19610,9588,917
Close PriceClose₹814.302,029.10935.052,263.20291.15696.20967.30
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE17.7422.3856.2966.8623.5629.3014.46
Price To SalesPS5.176.471.658.883.892.271.71
RevenueRevenueCr3,0892,3839,0121,5593,3924,8265,213
Revenue Growth TTMRev Gr TTM%-29.6%16.8%18.3%20.0%24.2%17.5%11.3%
PAT Growth TTMPAT Gr TTM%-56.4%17.4%-44.7%18.3%60.2%12.8%54.3%
Annual Reports
Quarterly Reports
Load More
Interviews